(UMRX) – Globe Newswire
-
Cogent Biosciences to Present at 11th Annual SVB Leerink Global Healthcare Conference
-
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
-
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
-
Unum Therapeutics Reports First Quarter Financial Results and Provides Corporate Updates
-
Unum Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Updates
-
Unum Therapeutics Announces Common Stock Purchase Agreement for up to $25 Million with Lincoln Park Capital
-
Unum Therapeutics Implements Strategic Restructuring to Prioritize Efforts on BOXR1030 for the Treatment of Solid Tumor Cancers
-
Unum Therapeutics Provides Updates to its Phase 1 Trial of ACTR707 for HER2+ Solid Tumor Cancers
-
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting
-
Unum Therapeutics to Present at Upcoming Investor Conference
-
Unum Therapeutics Reports Third Quarter 2019 Financial Results
-
Unum Therapeutics Presents Preclinical Data for BOXR1030 at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Unum Therapeutics Announces Strategic Focus on Developing Best-in-Class Cellular Therapies for Solid Tumor Cancers
-
Unum Therapeutics Announces Data Presentation at the Upcoming Society for Immunotherapy of Cancer (SITC) Meeting
-
Unum Therapeutics to Present at Upcoming Industry Conferences in September
-
Unum Therapeutics to Present at Upcoming September Investor Conferences
-
Unum Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Updates
-
Unum Therapeutics to Review Second Quarter 2019 Financial Results on August 12, 2019
-
Unum Therapeutics Announces New Appointments to its Board of Directors
Back to UMRX Stock Lookup
